What is NanoImaging Services?
NanoImaging Services operates as a premier Contract Research Organization (CRO) that bridges the gap between complex structural biology and commercial drug development. The company provides essential services including high-resolution cryo-electron microscopy, nanoparticle characterization, and GMP-compliant imaging workflows. Following the strategic acquisition of Proteos, NIS has successfully integrated protein production into its service portfolio, creating a comprehensive, end-to-end solution for pharmaceutical and biotechnology partners. This vertical integration allows NIS to address the growing demand for precise structural data, which is vital for modern therapeutic design and the rapid identification of drug candidates.
How much funding has NanoImaging Services raised?
NanoImaging Services has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in NanoImaging Services
PPP
Public-Private Partnership
What's next for NanoImaging Services?
With the recent influx of capital, NanoImaging Services is positioned to accelerate its operational expansion and technological footprint. The firm is expected to focus on increasing its in-house microscope capacity and enhancing its GMP-compliant infrastructure to meet the rigorous standards of late-stage clinical trials. By deepening its expertise in structural biology and protein production, NIS is well-equipped to capture a larger share of the outsourced R&D market. Future strategic initiatives will likely prioritize the optimization of high-throughput workflows, enabling the company to serve as a primary partner for global biopharma entities navigating the complexities of modern drug discovery and development.
See full NanoImaging Services company page
